Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial - Kropff, Martin; Hillengaß, Jens; Möhler, Thomas (Haematologica, the hematology journal, 2012)
Gesehen am 26.07.2017